The BAM15-induced improvements in glucose tolerance, compared with WD control mice, were associated with a dose-dependent decrease in fasting blood glucose (Fig. 3h) and decreased random-fed serum insulin levels (Fig. 3i). This evidence concerns the gene INS and Wilson disease.